The Role of the Microbiome in the Development of an Autoimmune Reaction in Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA), a chronic inflammatory illness, have joint inflammation, increasing tissue damage, and severe disability, all of which negatively impact quality of life. While the precise mechanisms behind RA remain unknown, there is growing evidence that both the onset and development of the illness are closely linked to an imbalance in the intestinal microbiota. Variations in the microbial content of RA patients and healthy people suggest that the gut microbiota plays a part in regulating immunological responses and fostering inflammation. Thus, therapies aimed at restoring the microbiome to its original state have demonstrated encouraging results in terms of increasing therapeutic efficacy, improving patient outcomes, and delaying the progression of disease. However, more research is needed to clarify the intricate interactions between the intestinal microbiota and autoimmunity mechanisms in RA.